Vertex Pharmaceuticals (VRTX) is gaining attention as new clinical data for its kidney disease therapy, povetacicept, shows ...

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be announcing earnings results this Monday after market hours. Here’s what you need to know.

Return on Assets (ROA): Vertex's financial strength is reflected in its exceptional ROA, which exceeds industry averages.

Pfizer is racing towards patent cliffs that will lead to even worse financial results. Vertex Pharmaceuticals is posting ...

Analysts expect Vertex Pharmaceuticals to report an earnings per share (EPS) of $4.35. Investors in Vertex Pharmaceuticals are eagerly awaiting the company's announcement, hoping for news of ...

Vertex Pharmaceuticals Incorporated's stock has shown resilience, recovering from dips and maintaining a strong long-term growth trajectory, driven by its robust CF franchise and new product approvals ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the presentation of multiple abstracts demonstrating the clinical benefits of treatment with CFTR modulators, including the Company’s ...

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is one of the most profitable biotech stocks to buy. H.C. Wainwright ...

In a significant move within Vertex (NASDAQ:VRTX), Inc. (NASDAQ:VERX), an insider has executed a large stock sale, according to recent SEC filings. Jeffrey Westphal, a ten percent owner of the company ...

MADISON, Miss., May 18, 2022 (GLOBE NEWSWIRE) -- The Vertex Company was awarded a contract valued up to $130 million to maintain helicopters for the U.S. Air Force Global Strike Command, known as ...

Vertex, Inc. (NASDAQ:VERX) is one of the Best Beaten Down Growth Stocks to Buy According to Analysts. Wall Street has a mixed ...

MADISON, Miss., Oct. 03, 2022 (GLOBE NEWSWIRE) -- The Vertex Company, a V2X company (NYSE: VVX), was awarded a contract valued up to $280 million to maintain the U.S. Navy’s aircraft used to train ...